Long-term effect of cinacalcet hydrochloride on abdominal aortic calcification in patients on hemodialysis with secondary hyperparathyroidism

Background: Secondary hyperparathyroidism (SHPT) is one of the common complications in dialysis patients, and is associated with increased risk of vascular calcification. The effects of cinacalcet hydrochloride treatment on bone and mineral metabolism have been previously reported, but the benefit of cinacalcet on vascular calcification remains uncertain. The aim of this study was to evaluate the impact of cinacalcet on abdominal aortic calcification in dialysis patients. Subjects and methods: Patients were on maintenance hemodialysis with insufficiently controlled SHPT (intact parathyroid hormone [PTH] >180 pg/mL) by conventional therapies. All subjects were initially administered 25 mg cinacalcet daily, with concomitant use of calcitriol analogs. Abdominal aortic calcification was annually evaluated by calculating aortic calcification area index (ACAI) using multidetector computed tomography (MDCT), from 12 months before to 36 months after the initiation of cinacalcet therapy. Results: Twenty-three patients were analyzed in this study. The mean age was 59.0±8.7 years, 34.8% were women, and the mean dialysis duration was 163.0±76.0 months. After administration of cinacalcet, serum levels of intact PTH, phosphorus, and calcium significantly decreased, and mean Ca × P values significantly decreased from 67.4±7.9 mg2/dL2 to 52±7.7 mg2/dL2. Although the ACAI value did not decrease during the observation period, the increase in ACAI between 24 months and 36 months after cinacalcet administration was significantly suppressed. Conclusion: Long-term administration of cinacalcet was associated with reduced progression of abdominal aortic calcification, and achieving appropriate calcium and phosphorus levels may reduce the rates of cardiovascular events and mortality in patients on hemodialysis

Technical developments for accurate determination of amount of samples used for TOF measurements

Activity determination of 241,243Am samples has been performed with two separate methods of calorimetry and gamma-ray spectroscopy. Decay heat measurements of the samples were carried out by using a calorimeter, and activities of the samples were accurately determined with uncertainties less than 0.45%. The primary source of uncertainty in the calorimetric method is the accuracy of available half-life data. Gamma-ray detection efficiencies of a HPGe detector were determined with uncertainties of 1.5% by combining measured efficiencies and Monte Carlo simulation. Activities of the samples were determined with uncertainties less than 2.0% by gamma-ray spectroscopy and were concordant with those of the calorimetry

Research and development for accuracy improvement of neutron nuclear data on minor actinides

To improve accuracy of neutron nuclear data on minor actinides, a Japanese nuclear data project entitled “Research and development for Accuracy Improvement of neutron nuclear data on Minor ACtinides (AIMAC)” has been implemented. Several independent measurement techniques were developed for improving measurement precision at J-PARC/MLF/ANNRI and KURRI/LINAC facilities. Effectiveness of combining the independent techniques has been demonstrated for identifying bias effects and improving accuracy, especially in characterization of samples used for nuclear data measurements. Capture cross sections and/or total cross sections have been measured for Am-241, Am-243, Np-237, Tc-99, Gd-155, and Gd-157. Systematic nuclear data evaluation has also been performed by taking into account the identified bias effect. Highlights of the AIMAC project are outlined

The serum vaspin levels are reduced in Japanese chronic hemodialysis patients

Background: Visceral adipose tissue-derived serine proteinase inhibitor (vaspin) is an adipokine identified in genetically obese rats that correlates with insulin resistance and obesity in humans. Recently, we found that 7% of the Japanese population with the minor allele sequence (A) of rs77060950 exhibit higher levels of serum vaspin. We therefore evaluated the serum vaspin levels in Japanese chronic hemodialysis patients. Methods: Healthy Japanese control volunteers (control; n = 95, 49.9 +/- 6.91 years) and Japanese patients undergoing hemodialysis therapy (HD; n = 138, 51.4 +/- 10.5 years) were enrolled in this study, and serum samples were subjected to the human vaspin RIA system. Results: The measurement of the serum vaspin levels demonstrated that a fraction of control subjects (n = 5) and HD patients (n = 11) exhibited much higher levels (> 10 ng/ml; Vaspin(High) group), while the rest of the population exhibited lower levels (< 3 ng/ml; Vaspin(Low) group). By comparing the patients in the Vaspin(Low) group, the serum vaspin levels were found to be significantly higher in the control subjects (0.87 +/- 0.24 ng/ml) than in the HD patients (0.32 +/- 0.15 ng/ml) (p < 0.0001). In the stepwise regression analyses, the serum creatinine and triglyceride levels were found to be independently and significantly associated with the vaspin concentrations in all subjects. Conclusions: The creatinine levels are negatively correlated with the serum vaspin levels and were significantly reduced in the Japanese HD patients in the Vaspin(Low) group

Measurement of the neutron capture cross section of 99Tc using ANNRI at J-PARC

The neutron capture cross section of 99Tc was measured using NaI(Tl) detectors of the Accurate Neutron-Nucleus Reaction Measurement Instrument (ANNRI) at the Japan Proton Accelerator Research Complex (J-PARC) in the energy range from thermal to the keV energy region. Preliminary results were presented and compared with previous measurements and evaluations

Technical developments for accurate determination of amount of samples used for TOF measurements

Activity determination of 241,243Am samples has been performed with two separate methods of calorimetry and gamma-ray spectroscopy. Decay heat measurements of the samples were carried out by using a calorimeter, and activities of the samples were accurately determined with uncertainties less than 0.45%. The primary source of uncertainty in the calorimetric method is the accuracy of available half-life data. Gamma-ray detection efficiencies of a HPGe detector were determined with uncertainties of 1.5% by combining measured efficiencies and Monte Carlo simulation. Activities of the samples were determined with uncertainties less than 2.0% by gamma-ray spectroscopy and were concordant with those of the calorimetry

Technical developments for accurate determination of amount of samples used for TOF measurements

Activity determination of 241,243Am samples has been performed with two separate methods of calorimetry and gamma-ray spectroscopy. Decay heat measurements of the samples were carried out by using a calorimeter, and activities of the samples were accurately determined with uncertainties less than 0.45%. The primary source of uncertainty in the calorimetric method is the accuracy of available half-life data. Gamma-ray detection efficiencies of a HPGe detector were determined with uncertainties of 1.5% by combining measured efficiencies and Monte Carlo simulation. Activities of the samples were determined with uncertainties less than 2.0% by gamma-ray spectroscopy and were concordant with those of the calorimetry